These observations indicate the influence of IOP‐lowering medications on TGFβ‐mediated cellular response in hTM cells and also confirm the plausible causal role of PG+BB in reducing the pro‐fibrotic status in TM tissue in glaucoma patients. Here, TGFB1 is linked to glaucoma.